TF
IMMU

Trutina Financial’s Immunomedics Inc IMMU Stock Holding History

Trutina Financial’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-250
Closed -$1K – 286
2014
Q1 		$1K Buy
+250
New +$1.24K ﹤0.01% 330

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Trutina Financial's IMMU Position: Q2 2014 in Review

Trutina Financial sold out of Immunomedics Inc (IMMU) in Q2 2014, closing a stake of 250 shares — an estimated $1K sold.

Trutina Financial first reported a position in IMMU in Q1 2014 and held it in 1 quarter. The position peaked at $1K in Q1 2014. 76 funds tracked by Wall St. Rank hold IMMU as of Q2 2014.

  • Trutina Financial reported no remaining Immunomedics Inc position as of Q2 2014 after selling out during the quarter.
  • Trutina Financial sold 250 Immunomedics Inc shares in Q2 2014, an estimated $1K.
  • Trutina Financial first reported a position in Immunomedics Inc in Q1 2014 and held it in 1 quarter.
  • Trutina Financial's Immunomedics Inc position peaked at $1K in Q1 2014.
  • 76 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2014.

Based on Trutina Financial's 13F filing for Q2 2014, filed 14 Aug 2014.